2023, Year in Review
Message from the Precision Cancer Consortium Chair

We are all here on this journey together, with the same mission and vision– that is to do more for patients with cancer through improving access to innovative technologies, such as Next-Generation Sequencing (NGS). Information from Comprehensive Genomic Profiling (CGP) is empowering for both doctors and patients, as it can unlock new therapeutic solutions that may have not otherwise been available in the absence of this data.

By making innovative advancements like CGP more accessible, we are putting the power in the hands of doctors and patients to have more insights into the biological underpinnings of what may be causing disease, and ultimately our hope is this will have a positive impact on patients.

Click on the image, or button to download the annual report.

PCC-038 Date of preparation: May 2024